Chapter 51 Answering Questions from Journalists
Ogawa cheekily once again asked his book friends for collections and recommendations.
-----------
"Next, this lady. Chen Qiuyu pointed to a blonde European lady.
"Hello Miss Chen, I am a reporter from The Times, and the price of your company's 'prebiotics' is so high, which is unfair to most cancer patients. What do you think about this?"
"According to our understanding, the cost of treating terminal diseases, including cancer, within the scope of Shijie has been high, such as liver exchange surgery for liver cancer in Huaguo, and the overall cost of early treatment and later anti-rejection reaction will not be less than 1 million yuan. In addition, the survival time of patients who have undergone liver exchange surgery is not more than 5 years.
If there were two treatments with the same cost, the treatment of liver cancer with 'probiotics' and the treatment of liver cancer with surgery and liver exchange, which treatment do you think patients would use?
The overall cost of the same surgery in developed countries is also more than $500,000, if both treatments exist, do you think they would use liver replacement surgery to save $500,000?
This is one of the reasons why we set the price of 'probiotics', which is basically the same as the cost of treatment for the same condition today.
Second, the company determines the sales price based on the production cost of the 'prebiotic'. The journalists present here have a certain understanding of the elements of price setting, and the cost of research will account for a certain proportion of it.
Third, we deeply feel that the company's production capacity cannot meet the needs of the majority of cancer patients in Huaguo and even Shijie. In order to increase the company's production capacity as soon as possible, we also need to raise a large amount of funds to continuously expand our production capacity to meet the growing needs of cancer patients and make the greatest efforts to eliminate cancer within the scope of Shijie.
Cancer patients who have received 'prebiotic' treatment in the early stage are the biggest beneficiary group, and while the company has met their needs, they have also contributed to the development and growth of the company.
The reporters in the venue were speechless for a while, and there was such a domineering thing. You need to keep expanding your capacity, and patients have to keep funding you, and if you don't provide it, it's better than a robber.
The reporters secretly compared the behavior of some monopoly industries with Star Pharmaceutical, and it is true that other industries cannot have such irreplaceable and determined demand.
For example, if I don't have a micro-hardware company, I can use software from other companies. Even if I don't have another software company, I can always use a computer.
But cancer patients really can't do without "prebiotics". This is also the reason why "Star Pharmaceutical" dares to openly blackmail Shijie, and the blackmailed person can only accept it willingly.
Next, a Japanese reporter asked: "Miss Chen, I am a reporter for the Great Japanese Daily News, and you know that Shijie has about 1.651% of the world's population, which means that about 1 in 59 people have cancer, and there are more than 6 billion people in the world, and there are more than 100 million cancer patients."
In order to save the lives of thousands of cancer patients, will your company consider disclosing the manufacturing and process of 'prebiotics' to the public, so that more capable companies can participate in the production of 'prebiotics' to meet the needs of cancer patients to the greatest extent. ”
The reporters in the audience all looked at this reporter with foolish eyes, it is not terrible for an idiot to be an idiot, but it is terrible to be an idiot who is a reporter.
The meeting hall was noisy, and the voices of reprimanding the reporter filled the entire venue, and the reporters present generally believed that this kind of sensational, high-sounding, and ill-intentioned problem could only be raised by a reporter from a rogue country like the Japanese state.
He felt that this problem not only made him out of the limelight, but also dug a big pit for Star Pharmaceutical, so that Star Pharmaceutical sank in the whirlpool of morality.
"I am touched by your sentiment of praying for the blessings of the people of Shijie, and I think that all the entrepreneurs and managers of the Wa Kingdom will also be moved by your noble character.
I hope that you can return to China and call on the big companies in the country, such as Mitsubishi Heavy Industries, Mitsui Heavy Industries, Sony, etc., to let them disclose all their proprietary jishu and production processes to Shijie, so that Shijie's scientific Jishu development can change with each passing day, and make more and more Haode products to meet the needs of Shijie people and benefit Shijie people.
We will also actively respond to the initiative of Japanese companies and companies in Shijie countries together with our customers, and disclose our jishu and production processes, so you can rest assured that we will never break our promises. ”
Ms. Chen Qiuyu's words made Little Inu Erlang's face pale.
Ms. Chen Qiuyu continued: "Star Pharmaceutical is only a small company, with fixed assets of only 10 million US dollars.
But our biggest advantage is that we have the most dedicated scientific researchers, in order to be able to give full play to their ingenuity, develop more and more drugs to relieve the pain of all kinds of patients.
The company will provide them with better and more advanced shiyan conditions, which requires us to increase investment in scientific research.
I can disclose to reporters in advance that the company's other special drug for kidney disease, "Kidney Kang", is about to enter the clinical trial stage, which can dredge the renal tubular lumen obstruction, repair the damage caused by renal tubular necrosis or renal tubular wall rupture after injury, and can make the glomerular cells quickly restore their function.
'Kidney Health' is a high-tech biological gene therapy drug that can make patients with kidney failure and necrosis fully recover within eight hours after injection. It avoids the pain of kidney replacement and the short survival time of patients with severe kidney disease, so that patients can have a healthy kidney completely. As long as there are no other serious complications in patients with kidney disease, the cure rate of 'Kidney Health' is 100%. ”
The reporters in the audience were boiling again, and the experts from the Shijie Health Organization and the Huaguo Food and Drug Administration, who were sitting in the first row, couldn't sit still and began to exchange information with each other from the news released by Chen Qiuyu.
One of the doctors from a well-known German medical research institute stood up and said: "Ms. Chen, today is not April Fool's Day, I believe that Ms. Chen's news release was approved by Chairman Chen Ning, but I still have to ask, is this true? This is too unbelievable." ”
Chen Qiuyu told the German expert: "Dr. Felix, the application report and attachments for the Phase 1 clinical trial of 'Kidney Kang' will be submitted to the China Food and Drug Administration in the near future.
The company sincerely invites Dr. Felix and experts from the Shijie Health Organization to participate in the clinical trial of the biogene drug 'Kidney Health' and supervise and evaluate it. She nodded to Dr. Felix and motioned for him to sit down.
For mobile phone users, please read it on m.qidian.com.